Paradigm cuts 20% of jobs in drive for profitability:
This article was originally published in Clinica
Surgical and diagnostic company Paradigm Medical Industries is to slash its workforce by 20% as part of a "corporate downsizing" programme in an attempt to reach profitability this year. It will also cut many external services, the Salt Lake City, Utah company says. "The cost-savings initiatives will provide the company with a greater return on increased revenues this year," said Thomas Motter, Paradigm's CEO. The company does not anticipate material expenses as a result of the initiative.
You may also be interested in...
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.
The first of around 260 patients for a clinical trial comparing its PB006 natalizumab biosimilar candidate to Biogen’s Tysabri reference brand have been recruited by Polpharma Biologics, which has just added Karsten Roth and Alexandra Moulson to its team.